Annual FCF
-$119.13 M
-$14.51 M-13.87%
December 31, 2022
Summary
- As of February 10, 2025, KDNY annual free cash flow is -$119.13 million, with the most recent change of -$14.51 million (-13.87%) on December 31, 2022.
- During the last 3 years, KDNY annual FCF has fallen by -$104.79 million (-730.43%).
Performance
KDNY Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly FCF
-$61.81 M
-$10.22 M-19.81%
June 30, 2023
Summary
- As of February 10, 2025, KDNY quarterly free cash flow is -$61.81 million, with the most recent change of -$10.22 million (-19.81%) on June 30, 2023.
- Over the past year, KDNY quarterly FCF has dropped by -$30.97 million (-100.40%).
Performance
KDNY Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM FCF
-$176.60 M
-$30.97 M-21.27%
June 30, 2023
Summary
- As of February 10, 2025, KDNY TTM free cash flow is -$176.60 million, with the most recent change of -$30.97 million (-21.27%) on June 30, 2023.
- Over the past year, KDNY TTM FCF has dropped by -$72.30 million (-69.31%).
Performance
KDNY TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
KDNY Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -13.9% | -100.4% | -69.3% |
| 3 y3 years | -730.4% | -1409.1% | -2221.9% |
| 5 y5 years | -730.4% | - | - |
KDNY Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | +13.9% | at low | +170.1% | at low | +74.8% | at low |
| 5 y | 5-year | +730.4% | at low | +1661.1% | at low | +4931.4% | at low |
| alltime | all time | +730.4% | at low | +1661.1% | at low | +4931.4% | at low |
Chinook Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | -$61.81 M(+19.8%) | -$176.60 M(+21.3%) |
| Mar 2023 | - | -$51.59 M(+37.5%) | -$145.63 M(+22.2%) |
| Dec 2022 | -$119.13 M(+13.9%) | -$37.51 M(+46.1%) | -$119.13 M(+14.0%) |
| Sep 2022 | - | -$25.68 M(-16.7%) | -$104.50 M(+0.2%) |
| Jun 2022 | - | -$30.84 M(+22.9%) | -$104.31 M(+3.2%) |
| Mar 2022 | - | -$25.10 M(+9.7%) | -$101.04 M(-3.4%) |
| Dec 2021 | -$104.62 M | -$22.88 M(-10.2%) | -$104.62 M(-15.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$25.48 M(-7.6%) | -$123.83 M(+17.6%) |
| Jun 2021 | - | -$27.58 M(-3.8%) | -$105.30 M(+28.7%) |
| Mar 2021 | - | -$28.68 M(-31.9%) | -$81.81 M(+44.4%) |
| Dec 2020 | -$56.65 M(+294.8%) | -$42.09 M(+506.2%) | -$56.65 M(+289.3%) |
| Sep 2020 | - | -$6.94 M(+69.5%) | -$14.55 M(+91.3%) |
| Jun 2020 | - | -$4.10 M(+16.7%) | -$7.61 M(+116.7%) |
| Mar 2020 | - | -$3.51 M | -$3.51 M |
| Dec 2019 | -$14.35 M | - | - |
FAQ
- What is Chinook Therapeutics annual free cash flow?
- What is the all time high annual FCF for Chinook Therapeutics?
- What is Chinook Therapeutics annual FCF year-on-year change?
- What is Chinook Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Chinook Therapeutics?
- What is Chinook Therapeutics quarterly FCF year-on-year change?
- What is Chinook Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Chinook Therapeutics?
- What is Chinook Therapeutics TTM FCF year-on-year change?
What is Chinook Therapeutics annual free cash flow?
The current annual FCF of KDNY is -$119.13 M
What is the all time high annual FCF for Chinook Therapeutics?
Chinook Therapeutics all-time high annual free cash flow is -$14.35 M
What is Chinook Therapeutics annual FCF year-on-year change?
Over the past year, KDNY annual free cash flow has changed by -$14.51 M (-13.87%)
What is Chinook Therapeutics quarterly free cash flow?
The current quarterly FCF of KDNY is -$61.81 M
What is the all time high quarterly FCF for Chinook Therapeutics?
Chinook Therapeutics all-time high quarterly free cash flow is -$3.51 M
What is Chinook Therapeutics quarterly FCF year-on-year change?
Over the past year, KDNY quarterly free cash flow has changed by -$30.97 M (-100.40%)
What is Chinook Therapeutics TTM free cash flow?
The current TTM FCF of KDNY is -$176.60 M
What is the all time high TTM FCF for Chinook Therapeutics?
Chinook Therapeutics all-time high TTM free cash flow is -$3.51 M
What is Chinook Therapeutics TTM FCF year-on-year change?
Over the past year, KDNY TTM free cash flow has changed by -$72.30 M (-69.31%)